Medication info
Eglyduo Extended-Release Tablet 0.3/1000 mg (Empagliflozin, Metformin Hydrochloride)

Eglyduo Extended-Release Tablet 0.3/1000 mg (Empagliflozin, Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Enavogliflozin›0.3mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Hanol BioPharma Co., Ltd.
Appearance
Oval extended-release bilayer tablet, white and light pink in color
Packaging
30 tablets/bottle, 300 tablets/bottle, 28 tablets/box [(7 tablets/PTP) X 4]
Approval status
Active

MFDS item code 202302006 · Approved 2023.06.29

Summary

Main use
Improves blood glucose control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer 1 tablet once daily with a meal to patients receiving 0.3 mg of inavogliflozin and 1000 mg of extended-release metformin hydrochloride. No dosage adjustment is necessary in patients with mild renal impairment. Treatment with this drug should not be initiated in patients with an estimated glomerular filtration rate (eGFR) of less than 60 mL/min/1.73m2. This drug should be discontinued if the eGFR persistently remains below 60 mL/min/1.73m2.

Ingredients

Manufacturer
Hanol BioPharma Co., Ltd.

Efficacy & effects

Improves blood glucose control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to help control blood sugar in patients with type 2 diabetes along with dietary and exercise therapy. In other words, it helps effectively manage blood sugar levels to improve symptoms of diabetes. It also contributes to the prevention of diabetes complications through healthy blood sugar management.

How to take

Adult dose

Administer 1 tablet once daily with a meal to patients receiving 0.3 mg of inavogliflozin and 1000 mg of extended-release metformin hydrochloride. No dosage adjustment is necessary in patients with mild renal impairment. Treatment with this drug should not be initiated in patients with an estimated glomerular filtration rate (eGFR) of less than 60 mL/min/1.73m2. This drug should be discontinued if the eGFR persistently remains below 60 mL/min/1.73m2.

Precautions

This medication is composed of two main ingredients, each with effects on the body and points to be cautious of. First, the Metformin Hydrochloride contained in this medication helps control blood sugar but can sometimes cause severe lactic acidosis. Lactic acidosis is a rare complication that occurs due to excessive accumulation of lactic acid in the body, and one should consult a healthcare provider immediately if symptoms appear. This medication should not be administered to certain patients. For example, those allergic to this medication or any of its components, those with severely impaired kidney function, those with acute infections or dehydration, patients with type 1 diabetes, individuals experiencing acute cardiac issues, and those undergoing imaging studies with radiographic contrast agents should avoid using this medication. Patients with fluid depletion, impaired kidney function, heart failure, irregular eating habits, or those who consume alcohol excessively should use this medication cautiously. Moreover, a serious condition called ketoacidosis, characterized by increased acidity in the blood, can occur, and immediate treatment is necessary if related symptoms appear. One of this medication's ingredients may increase the risk of urinary and genital infections, so immediate treatment is required if infection symptoms develop. Additionally, this medication can affect body fluid status, requiring special caution in individuals at risk of dehydration. While taking this medication, gastrointestinal disturbances may occur, including nausea, diarrhea, abdominal pain, etc., but most improve with time. If symptoms worsen, consultation with a healthcare provider is advised. This medication is not recommended for use in pregnant or breastfeeding women, and should be discontinued if pregnancy is confirmed. In elderly patients, the likelihood of impaired kidney function is higher, so kidney function should be regularly monitored and their condition closely observed while using this medication. In cases of overdose, seek immediate medical attention for appropriate treatment, and the components of this medication can be removed through blood dialysis. Finally, this medication should not be broken, crushed, or chewed, and must be swallowed whole; it should be kept out of reach of children.

Side effects

  • Severe lactic acidosis
  • hypoglycemia
  • dyspepsia
  • constipation
  • gastritis
  • upper abdominal pain
  • abdominal pain
  • diarrhea
  • dry mouth
  • enterocolitis
Show 112 more
  • blood in stool
  • vaginal infection
  • cystitis
  • latent tuberculosis
  • upper respiratory infection
  • anal abscess
  • folliculitis
  • pyelonephritis
  • tinea
  • arthralgia
  • lower back pain
  • intervertebral disc degeneration
  • spinal osteoarthritis
  • cervical stenosis
  • groin pain
  • musculoskeletal chest pain
  • contusion
  • ligament rupture
  • ligament sprain
  • wrist fracture
  • sting from arthropod
  • epicondylitis
  • muscle strain
  • headache
  • dizziness
  • sensory disturbance
  • friction urticaria
  • dyslipidemia
  • hyperlipidemia
  • benign prostatic hyperplasia
  • genital pruritus
  • cervical polyp
  • genital erythema
  • dysuria
  • nocturia
  • polyuria
  • cardiac hypertrophy
  • worsening condition
  • cough
  • respiratory distress
  • increased aspartate aminotransferase
  • increased alanine aminotransferase
  • anemia
  • bone marrow suppression
  • hypertension
  • orthostatic hypotension
  • insomnia
  • anxiety
  • subacute thyroiditis
  • dyspepsia
  • gastritis
  • gastroesophageal reflux disease
  • mechanical intestinal obstruction
  • chronic gastritis
  • periodontitis
  • vaginal infection
  • cystitis
  • arthralgia
  • myalgia
  • headache
  • pruritus
  • hypoglycemia
  • vulvar pruritus
  • frequency of urination
  • nephrolithiasis
  • renal cyst
  • cholelithiasis
  • unstable angina
  • chest pain
  • dysmenorrhea
  • vaginal bleeding
  • asthenia
  • decreased blood pressure
  • increased blood pressure
  • falls
  • skin laceration
  • drowsiness
  • sleepiness
  • postural vertigo
  • angina
  • palpitations
  • dyspnea
  • hair loss
  • heat rash
  • limb pain
  • calcification of muscles
  • flank pain
  • spinal osteoarthritis
  • dysuria
  • dysmenorrhea
  • vaginal bleeding
  • asthenia
  • decreased blood pressure
  • increased blood pressure
  • falls
  • skin laceration
  • food allergy
  • hypothyroidism
  • thyroid cyst
  • thyroid nodule
  • urticaria
  • hematuria
  • sexual dysfunction
  • concussion
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • erythema
  • itching
  • rash

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a sealed container. A storage temperature between 1 and 30 degrees Celsius is recommended.

Appearance and packaging

Appearance

Oval extended-release bilayer tablet, white and light pink in color

Package unit

30 tablets/bottle, 300 tablets/bottle, 28 tablets/box [(7 tablets/PTP) X 4]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.